Clinical trial

Insulin Regulation of Lipolysis and Lipolysis Proteins

NCT03866408

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2018-11-12

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2018-11-12Date precision: day

Registry last updated2026-01-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Immediate weight lossBEHAVIORAL

PioglitazoneDRUG · verified · RxNorm: pioglitazone

Deferred weight lossBEHAVIORAL

PlaceboDRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03866408 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.